Cd8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Pathway Diagram
Mermaid diagram (expand to render)
Overview
CD8 (Cluster of Differentiation 8) is a co-receptor expressed on the surface of cytotoxic T lymphocytes (CTLs) and some natural killer (NK) cells. While traditionally studied in the context of adaptive immunity, CD8+ T cells have emerged as important players in neuroinflammation and neurodegenerative diseases. This page covers the CD8 gene structure, protein function, and its role in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and other neurodegenerative conditions. [@gate2020]
Gene Information
Gene Structure
The CD8 co-receptor is composed of two polypeptide chains:
CD8A (Alpha Chain)
Encoded by gene on chromosome 2p11.2
Contains a signal peptide, V-type immunoglobulin domain, hinge region, transmembrane domain, and cytoplasmic tail
The cytoplasmic tail contains signaling motifs essential for T cell function
CD8B (Beta Chain)
Co-expressed with CD8A in most cytotoxic T cells
Forms disulfide-bonded heterodimer with CD8A
Contributes to stability and signaling
Protein Structure and Function
CD8 functions as a co-receptor in T cell receptor (TCR) signaling:
MHC Class I Recognition: CD8 binds to the α3 domain of MHC class I molecules, stabilizing TCR-peptide interaction
Signal Transduction: Lck (Src family kinase) associated with CD8 cytoplasmic tail initiates signaling cascades
Correlation between CD8+ T cell markers and disease progression
Parkinson's Disease
In Parkinson's disease:
Peripheral dysfunction: Reduced CD8+ T cell counts in early PD
[α-Synuclein](/proteins/alpha-synuclein) reactivity: CD8+ T cells respond to α-synuclein epitopes
Dopaminergic neuron toxicity: Potential direct cytotoxicity
Autoimmune components: Shared epitopes between neurons and pathogens
ALS (Amyotrophic Lateral Sclerosis)
CD8+ T cell infiltration in spinal cord
Cytotoxic killing of motor neurons (theoretical)
Regulatory dysfunction in end-stage disease
Multiple Sclerosis
CD8+ T cells as primary effector cells in demyelination
Epitope spreading to neuronal antigens
CD8+ T cell-mediated axonal injury
Therapeutic Implications
Immunomodulatory Approaches
Challenges
Balancing immune surveillance with suppression
CNS penetration of immunomodulatory drugs
Patient heterogeneity in immune profiles
Biomarkers
CD8+ T cell count: Peripheral blood marker
CD8+/CD4+ ratio: Immunosenescence indicator
Clonal TCR sequences: CNS-infiltrating T cell signatures
Soluble CD8: CSF biomarker candidate
Animal Models
CD8 knockout mice: Used to study CD8+ T cell function
Humanized mice: CD8+ T cell reconstitution for translational studies
α-Synuclein transgenic mice: CD8+ T cell response studies
Research Directions
Single-cell sequencing of CNS-infiltrating CD8+ T cells
TCR repertoire analysis in neurodegenerative diseases
Development of CNS-targeted immunomodulatory therapies
Understanding age-related changes in CD8+ T cell function
Background
The study of Cd8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.